© 2024 Hawaiʻi Public Radio
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Trump Now Claims 'Every American' Will Have Coronavirus Vaccine By April

President Trump speaks Friday at a news conference at the White House. He has made fast-tracking a vaccine against the coronavirus a core tenet of his reelection pitch.
Alex Wong
/
Getty Images
President Trump speaks Friday at a news conference at the White House. He has made fast-tracking a vaccine against the coronavirus a core tenet of his reelection pitch.

President Trump on Friday said "every American" will have a vaccine for the coronavirus available by April, escalating already ambitious goals to fast-track a vaccine for the virus that has killed nearly 200,000 people in the United States.

He also promised more than 100 million doses available by the end of the year. The most optimistic scenario included in a distribution plan that the Centers for Disease Control and Prevention released Wednesday would put the number of available vaccine doses at 45 million by the end of the year. Each person is expected to need two shots for protection against the coronavirus, so that would be enough for 22.5 million people.

During Friday's briefing, Trump said that distribution of a vaccine will begin within 24 hours of its readiness.

"I think distribution will go even quicker than most people think," he said.

The timeline for when a vaccine can reasonably be expected has been a point of contention within the federal government.

In Wednesday testimony to the Senate, CDC Director Robert Redfield said a vaccine against the coronavirus likely would not be available for widespread distribution until next summer or fall.

Trump later that day re-upped his pledge that a vaccine could be ready as soon as October and said that Redfield, a 30-year veteran in the field of virology and infectious disease, had "misunderstood" and "made a mistake" in his assessment of a vaccine's timing.

Operation Warp Speed, the federal government's coronavirus vaccine initiative, has six different vaccines at various stages of clinical testing. But challenges remain in getting the vaccines proved safe and effective and then authorized by the Food and Drug Administration and distributed.

Scott Hensley contributed to this report.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

Tags
NPR News NPR News
Alana Wise joined WAMU in September 2018 as the 2018-2020 Audion Reporting Fellow for Guns & America. Selected as one of 10 recipients nationwide of the Audion Reporting Fellowship, Alana works in the WAMU newsroom as part of a national reporting project and is spending two years focusing on the impact of guns in the Washington region.
Alana Wise
Alana Wise is a politics reporter on the Washington desk at NPR.
Related Stories